COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic to Host First Half 2017 Results Conference Call
18/08/2017
COPENHAGEN, Denmark - August 18, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2017 first half results on Friday, August 25, 2017. The management of Bavarian Nordic will host a conference call at [...]
Orion Corporation: Managers' transactions - Heikki Westerlund
18/08/2017
CORRECTION TO THE DISTRIBUTION ORION CORPORATION MANAGERS' TRANSACTIONS 18 th AUGUST 2017 at 13:45 EET/EEST Orion Corporation: Managers' transactions - Heikki Westerlund Correction to the distribution of the release [...]
Completion of exercise in full of overallotment option of 15%
18/08/2017
Company announcement - No. 38/2017 Zealand Pharma A/S has today registered a capital increase of 156,250 new shares as completion of exercise in full of overallotment option of 15% Copenhagen, August 18, 2017 - With [...]
Immunicum AB (publ): Interim Report Q2 - Corporate Update and Outlook
18/08/2017
Press Release 18 August 2017 Immunicum AB: Interim Report Q2 - Corporate Update and Outlook Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing an off-the-shelf immune system primer [...]
MITHRA ANNOUNCES FIRST SUBJECT COMPLETES ESTELLE® PHASE III STUDY
18/08/2017
MIThRA ANNOUNCES first subject completes ESTELLE® PhAse III study Estelle ® Phase III studies remain on track to report top line results in Q3 2018 and Q1 2019 in Europe/Russia and the US/Canada respectively Liège, [...]
Nicox annonce que son partenaire licencié exclusif mondial a déposé un mémoire relatif à la lettre de réponse (Complete Response Letter) pour la solution ophtalmique de latanoprostène bunod, 0,024%
18/08/2017
Communiqué de Presse Nicox annonce que son partenaire licencié exclusif mondial a déposé un mémoire relatif à la lettre de réponse ( Complete Response Letter ) pour la solution ophtalmique de latanoprostène bunod, 0,024 [...]
Nicox announces that its Exclusive Licensee Submits response to CRL for latanoprostene bunod ophthalmic solution, 0.024%
18/08/2017
Press Release Nicox announces that its Exclusive Licensee Submits response to CRL for latanoprostene bunod ophthalmic solution, 0.024% August 18, 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, [...]
Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
18/08/2017
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy [...]
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
17/08/2017
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]
Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financ...
17/08/2017
Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]
Medtronic EVP & CFO Karen L. Parkhill to Speak at Intellisight 2017 Conference
17/08/2017
DUBLIN - August 17, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CFA Society Minnesota's 6th Annual Investor Conference, Intellisight, on Wednesday [...]
Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency
17/08/2017
WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant [...]
ClearCorrect acquired by global dental leader Straumann Group
17/08/2017
ROUND ROCK, Texas, Aug. 17, 2017 (GLOBE NEWSWIRE) -- ClearCorrect, LLC, a leading manufacturer of clear aligners, is pleased to announce their acquisition by the Straumann Group, a global leader in tooth replacement [...]
Oxford BioMedica plc: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017
17/08/2017
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017 Oxford, UK - 17 August 2017: Oxford BioMedica plc ("OXB" or "the Group"; LSE: OXB), a leading gene and cell therapy group, today announces [...]
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
17/08/2017
RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, [...]
Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527
17/08/2017
Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527 Novel Bispecific Antibody Targeting Biological Pathway Implicated in [...]
Immunicum AB (publ) Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel
17/08/2017
Press Release 17 August 2017 Immunicum Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel Immunicum AB (publ; First North Premier: IMMU.ST), a biopharmaceutical company advancing [...]
argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
17/08/2017
Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]
ABLYNX WILL ANNOUNCE ITS 2017 HALF YEAR RESULTS WITH WEBCAST ON 24 AUGUST 2017
17/08/2017
GHENT, Belgium, 17 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will report its 2017 half year financial results and year-to-date business update on Thursday 24 August 2017 at 7.00 am CET. The Ablynx [...]

Pages